Skip to Main Content

For further information, see CMDT Part 40-23: Atropine & Anticholinergics Overdose

KEY FEATURES

  • Antimuscarinic agents with variable central nervous system effects

  • Atropine

  • Scopolamine

  • Belladonna

  • Datura stramonium

  • Hyoscyamus niger

  • Some mushrooms

  • Tricyclic antidepressants

  • Antihistamines

CLINICAL FINDINGS

  • Anticholinergic syndrome

    • Dryness of the mouth, thirst, difficulty swallowing, blurring of vision

    • Dilated pupils, flushed skin, tachycardia, fever, delirium, myoclonus, ileus

  • Antidepressants and antihistamines may induce convulsions

  • Diphenhydramine commonly causes delirium, tachycardia, and seizures; massive overdose may mimic tricyclic antidepressant cardiotoxic poisoning

DIAGNOSIS

  • Based on history of ingestion, typical "anticholinergic syndrome"

  • Serum levels not useful

  • ECG monitoring for wide QRS, QT prolongation

TREATMENT

  • Activated charcoal

    • Administer 60–100 g mixed in aqueous slurry orally or via gastric tube

    • Do not use for comatose or convulsing patients unless they are intubated with a cuffed endotracheal tube

  • External cooling and sedation, or neuromuscular paralysis in rare cases, are indicated to control high temperatures

  • For severe anticholinergic syndrome (eg, agitated delirium),

    • Give physostigmine salicylate, 0.5–1 mg intravenously slowly over 5 minutes, with ECG monitoring

    • Repeat as needed to total dose of no more than 2 mg

  • Caution: Bradyarrhythmias and convulsions are a hazard with physostigmine administration, and the drug should not be used in patients with evidence of cardiotoxic effects (eg, QRS interval prolongation) from tricyclic antidepressants or other sodium channel blockers

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.